Dr. Reddy'S Labs Launches Generic Syprine Capsules In Us Market

Dr. Reddy'S Laboratories Ltd Announced The Launch Of The Us Food And Drug Administration (Fda) Approved Trientine Hydrochloride Capsules Usp, 250 Mg, A Therapeutically Equivalent Generic Version Of Syprine (Trientine Hydrochloride) Capsules.Dr Reddy'S Trientine Hydrochloride Capsules Usp, 250 Mg Are Available In 100 Count Bottles."We Are Pleased To Provide This Convenient Alternative For Patients, Pharmacists And Distribution Partners," Explains Marc Kikuchi, Chief Executive Officer And Head Of Dr. Reddy'S North America Generics. "Our Product Can Be Stored At Room Temperature (20°C To 25°C Or 68° F To 77°F) Throughout The Product Shelf Life Of 24 Months."The Syprine Brand And Generic Products Had Us Sales Or Approximately Us$ 94.2 Million Mat For The Most Recent Twelve Months Ending In December 2019, According Toiqvia.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!